SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage.

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• Cells activate complex signaling networks, including AMPK and mTOR pathways, in response to DNA damage.
• ATM kinase initiates the AMPK-TSC2 pathway, inhibiting mTOR cascade following DNA double-strand breaks.
• SMYD3, a methyltransferase, has been identified to interact with both AMPK and mTOR in DNA damage response.

Purpose of the Study:

• To investigate the role of SMYD3 in the multiprotein complex involving AMPK and mTOR during DNA damage response.
• To elucidate the mechanism by which SMYD3 modulates the AMPK-mTOR signaling balance in cancer cells.
• To determine if SMYD3 directly modifies AMPK activity through methylation.

Main Methods:

• Extensive molecular characterization of gastrointestinal and breast cancer cells.
• Pharmacological inhibition of SMYD3 activity.
• Analysis of AMPK and mTOR pathway activation.
• Methylation site analysis of AMPK by SMYD3.

Main Results:

• SMYD3 forms a multiprotein complex with AMPK and mTOR involved in DNA damage response.
• SMYD3 inhibition suppresses AMPK activation and promotes the mTOR pathway upon DNA double-strand breaks.
• SMYD3 methylates AMPK at evolutionarily conserved residues Lys411 and Lys424.

Conclusions:

• SMYD3 plays a central role in balancing AMPK-mTOR signaling during cancer cell response to DNA double-strand breaks.
• SMYD3 acts as a molecular bridge connecting the AMPK and mTOR pathways following DNA damage.
• SMYD3-mediated methylation of AMPK is a key mechanism in this signaling crosstalk.